Sirolimus versus imatinib in patients with steroid-refractory chronic graft-versus-host disease: a retrospective analysis of a single-center

Objective To compare the efficacy and prognosis of imatinib and sirolimus as second-line treatment for steroid-refractory chronic graft-versus-host disease (SR-cGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods Clinical data of 33 patients diagnosed as SR-cGVHD afte...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: HE Yundi, HUANG Ruihao, HONG Tao, WANG Weihao, DU Yuxuan
Format: article
Langue:ZH
Publié: Editorial Office of Journal of Third Military Medical University 2021
Sujets:
Accès en ligne:https://doaj.org/article/413c7351afd84e67a2f6d92b036de682
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires